(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 160.78% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Alpha Cognition's revenue in 2025 is $4,586,341.On average, 2 Wall Street analysts forecast ACOG's revenue for 2025 to be $223,099,665, with the lowest ACOG revenue forecast at $214,938,467, and the highest ACOG revenue forecast at $231,260,862. On average, 2 Wall Street analysts forecast ACOG's revenue for 2026 to be $557,466,348, with the lowest ACOG revenue forecast at $515,529,105, and the highest ACOG revenue forecast at $599,403,590.
In 2027, ACOG is forecast to generate $1,483,560,247 in revenue, with the lowest revenue forecast at $1,483,560,247 and the highest revenue forecast at $1,483,560,247.